Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON

NCT02131220 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02131220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02131220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON
Lead sponsor
Fudan University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
September 30, 2017
Enrollment
362 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction, percutaneous coronary intervention, thrombolytic therapy